Dr Reddy's Laboratories Ltd
DRREDDY • Health Care
ROCE
22.76%
FY24 Actual
D/E Ratio
0.14
Leveraged
5Y Rev CAGR
13.2%
High Growth
Profit Margin
14.7%
5Y Average
| Metrics (Values in Cr) | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|---|---|
| Total Revenue | 19,386.9 | 22,099.9(+14.0%) | 25,762.2(+16.6%) | 28,920.1(+12.3%) | 33,762.9(+16.7%) | 36,101.6 |
| Operating Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| Operating Profit | — | — | — | — | — | — |
| Raw Profit | 6,869.4 | 7,796.1(+13.5%) | 7,586.8(-2.7%) | 8,889.2(+17.2%) | 10,524.6(+18.4%) | — |
| Operating Expenses | 1,959.5 | 2,729(+39.3%) | 2,410.6(-11.7%) | 1,914.6(-20.6%) | 2,693.4(+40.7%) | 26,613.3 |
| Selling General And Administrative Expenses | 2,398.3 | 2,976.1(+24.1%) | 3,199.3(+7.5%) | 3,710.2(+16.0%) | 4,736.3(+27.7%) | — |
| Depreciation And Amortization | 1,228.8 | 1,165.2(-5.2%) | 1,250.2(+7.3%) | 1,470(+17.6%) | 1,703.7(+15.9%) | 1,956.4 |
| Profit Before Interest | 2,980.5 | 3,157.2(+5.9%) | 6,191.3(+96.1%) | 7,372.1(+19.1%) | 7,962.4(+8.0%) | 7,531.9 |
| Interest Expense | 97 | 95.8(-1.2%) | 142.8(+49.1%) | 171.1(+19.8%) | 282.9(+65.3%) | 333.7 |
| Profit Before Tax | 2,883.5 | 3,061.4(+6.2%) | 6,048.5(+97.6%) | 7,201(+19.1%) | 7,679.5(+6.6%) | 7,198.2 |
| Tax Expense | 931.9 | 878.9(-5.7%) | 1,541.2(+75.4%) | 1,623.1(+5.3%) | 2,024.4(+24.7%) | 1,629.8 |
| Net Income | 1,951.6 | 2,182.5(+11.8%) | 4,507.3(+106.5%) | 5,577.9(+23.8%) | 5,655.1(+1.4%) | 5,568.4 |
| Earnings Per Share | 23.48 | 26.238(+11.7%) | 54.149(+106.4%) | 66.932(+23.6%) | 67.785(+1.3%) | 66.731 |
| Dividends Per Share | 5 | 6(+20.0%) | 8(+33.3%) | 8(0.0%) | 8(0.0%) | 8 |
| Payout Ratio | 0.213 | 0.229(+7.4%) | 0.148(-35.4%) | 0.12(-19.1%) | 0.118(-1.3%) | 0.12 |